Brief: Novabay Says Anticipates Reporting Q2 Net Sales Increased By About 100% And Operating Loss Declined By About 25% From Prior Quarter
July 21 (Reuters) - NovaBay Pharmaceuticals Inc NBY.A :
* NOVABAY - ANTICIPATES REPORTING Q2 NET SALES INCREASED BY
ABOUT
100% AND OPERATING LOSS DECLINED BY ABOUT 25% FROM PRIOR
QUARTER
Source text: [ID:https://bit.ly/3hnwZdS]
Further company coverage: NBY.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Stablecoin Development
See all newsBrief: Stablecoin Development Corporation Reports First Quarter 2026 Financial Results
Brief: Tether Says Participated In A $134 Million Financing Round For Stablecoin Development Corporation
Brief: Novabay Pharmaceuticals Announces Name Change To Stablecoin Development Corporation
Brief: Novabay Pharmaceuticals Says David Lazar Resigns As CEO
Brief: NovaBay Pharmaceuticals Files For Mixed Shelf Of Up To $200 Million - SEC Filing